A comparative study on 40 mg H 199/18 and 40 mg omeprazole with regard to effect on 24-hour intragastric pH in patients with symptomatic gastroesophageal reflux disease

Study identifier:D9612C00066

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A comparative study on 40 mg H 199/18 and 40 mg omeprazole with regard to effect on 24-hour intragastric pH in patients with symptomatic gastroesophageal reflux disease

Medical condition

Gastroesophageal Reflux Disease

Phase

Phase 1

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Oct 1999
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria